The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
109230979 10923097 9 F 20100303 20160915 20150317 20160920 EXP PHHY2010CA15776 NOVARTIS 55.90 YR M Y 100.00000 KG 20160920 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
109230979 10923097 1 PS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 40 MG, EVERY 4 WEEKS U S0092 21008 40 MG /month
109230979 10923097 2 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, EVERY 28 DAYS U 21008 30 MG /month
109230979 10923097 3 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, EVERY 3 WEEKS U 21008 30 MG
109230979 10923097 4 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, QMO (EVERY 4 WEEKS) U S0058 21008 30 MG /month
109230979 10923097 5 C ALTACE RAMIPRIL 1 Unknown QD (DAILY) U 0 QD
109230979 10923097 6 C ASA ASPIRIN 1 Unknown 80 MG, QD U 0 80 MG QD
109230979 10923097 7 C LANTUS INSULIN GLARGINE 1 Unknown QD (DAILY) U 0 INJECTION QD
109230979 10923097 8 C HUMULIN R INSULIN HUMAN 1 Unknown BID U 0 INJECTION BID
109230979 10923097 9 C CRESTOR ROSUVASTATIN CALCIUM 1 Unknown QD (DAILY) U 0 QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
109230979 10923097 1 Carcinoid tumour
109230979 10923097 5 Product used for unknown indication
109230979 10923097 6 Product used for unknown indication
109230979 10923097 7 Product used for unknown indication
109230979 10923097 8 Product used for unknown indication
109230979 10923097 9 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
109230979 10923097 OT
109230979 10923097 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
109230979 10923097 Bile duct obstruction
109230979 10923097 Blood glucose decreased
109230979 10923097 Blood pressure diastolic decreased
109230979 10923097 Blood pressure fluctuation
109230979 10923097 Blood pressure increased
109230979 10923097 Blood pressure systolic increased
109230979 10923097 Body temperature decreased
109230979 10923097 Chills
109230979 10923097 Diabetes mellitus
109230979 10923097 Discomfort
109230979 10923097 Heart rate decreased
109230979 10923097 Inappropriate schedule of drug administration
109230979 10923097 Incorrect dose administered
109230979 10923097 Jaundice
109230979 10923097 Needle issue
109230979 10923097 Ocular icterus
109230979 10923097 Orthostatic hypotension
109230979 10923097 Pain
109230979 10923097 Post procedural complication
109230979 10923097 Tremor
109230979 10923097 Underdose
109230979 10923097 Weight decreased
109230979 10923097 Yellow skin

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
109230979 10923097 1 20060710 0